NO IMPACT OF OBESITY ON POST-LIVER TRANSPLANTATION OUTCOME AMONG HCV-INFECTED LIVER TRANSPLANT RECIPIENTS

被引：0
|
作者：
Torres-Quevedo, R. [1 ,2 ]
Aguilera, V. [3 ,4 ]
Rubin, A. [3 ,4 ]
San Juan, F. [1 ]
Moya, A. [1 ]
Prieto, M. [3 ,4 ]
Mir, J. [1 ]
Berenguer, M. [3 ,4 ]
机构：
[1] Hosp La Fe, Liver Tranplantat & Surg Unit, E-46009 Valencia, Spain
[2] Univ Concepcion, Fac Med, Concepcion, Chile
[3] Hosp Univ La Fe, Serv Hepatogastroenterol, Valencia, Spain
[4] Inst Salud Carlos III, CIBEREHD, Valencia, Spain
来源：
JOURNAL OF HEPATOLOGY | 2010年 / 52卷
关键词：
D O I：
10.1016/S0168-8278(10)60453-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 50 条
  • [1] TRANSPLANTATION Steroid use in HCV-infected liver transplant recipients
    Roche, Bruno
    Samuel, Didier
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (04) : 198 - 200
  • [2] Steroid use in HCV-infected liver transplant recipients
    Bruno Roche
    Didier Samuel
    [J]. Nature Reviews Gastroenterology & Hepatology, 2009, 6 : 198 - 200
  • [3] Alarming decrease in patient survival among HCV-infected liver transplant recipients
    Berenguer, M
    Prieto, M
    Aguilera, V
    Nicolas, D
    Carrasco, D
    Rayon, M
    Mir, J
    Berenguer, J
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 32 - 33
  • [4] The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients
    Younossi, Z.
    Stepanova, M.
    Saab, S.
    Trimble, G.
    Mishra, A.
    Henry, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (02) : 209 - 217
  • [5] Plasma Cell Hepatitis in Post-Liver Transplant HCV-Infected Patients: The Columbia University Experience
    Saab, J.
    Salomao, M.
    Verna, E. C.
    Moreira, R. K.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 423A - 423A
  • [6] Plasma Cell Hepatitis in Post-Liver Transplant HCV-Infected Patients: The Columbia University Experience
    Saab, J.
    Salomao, M.
    Verna, E. C.
    Moreira, R. K.
    [J]. MODERN PATHOLOGY, 2012, 25 : 423A - 423A
  • [7] Recent decrease in patient survival among HCV-infected liver transplant recipients.
    Martinez, F
    Berenguer, M
    Prieto, M
    San Juan, F
    Rayon, M
    Mir, J
    Berenguer, J
    [J]. HEPATOLOGY, 2001, 34 (04) : 409A - 409A
  • [8] Acute rejection in HCV-infected liver transplant recipients: The great conundrum
    Burton, James R., Jr.
    Rosen, Hugo R.
    [J]. LIVER TRANSPLANTATION, 2006, 12 (11) : S38 - S47
  • [9] IMMUNOGENETIC FACTORS AFFECT SURVIVAL IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS
    Romagnoli, Renato
    Tandoi, Francesco
    Magistroni, Paola
    Bertinetto, Francesca
    Dametto, Ennia
    Martini, Silvia
    Dell'olio, Dominic
    Rizzetto, Mario
    Salizzoni, Mauro
    Amoroso, Antonio
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 22 - 22
  • [10] Impact of primary immunosuppression on allograft histology and viral levels in HCV-infected liver transplant recipients
    Charlton, MR
    Luna, LM
    Gonzalez-Koch, AR
    Poterucha, JJ
    Maor-Kendler, Y
    Batts, KP
    Wiesner, RH
    Rosen, CB
    Raghavakaimal, S
    [J]. HEPATOLOGY, 1999, 30 (04) : 658A - 658A
12345